Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 34 min ago
Peer-reviewedCC BY 4.0International Journal of Molecular Sciences

IgG-Mediated Hydrolysis of Neuregulin-1-Derived Peptides in 5xFAD Mice During the Development of Alzheimer’s Disease-like Pathology

  1. 1Knorre Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences, Novosibirsk 630090, Russia
  2. 2Institute of Systematics and Ecology of Animals, Siberian Branch of the Russian Academy of Sciences, Novosibirsk 630091, Russia

Abstract

Synaptic dysfunction and neurodegeneration in Alzheimer’s disease (AD) are accompanied by neuroinflammation and peripheral immune activation. Activation of humoral immunity is known to be associated with the formation of catalytic antibodies capable of catalytically degrading various antigens. Given the key role of neuregulin-1 (NRG1) in synaptic function and inflammation, and the possible involvement of catalytic antibodies in AD pathogenesis, we investigated IgG-mediated hydrolysis of three NRG1 peptides corresponding to the linker region cleaved during NRG1 maturation (C22), a conserved segment of the EGF-like domain (EGF23), and a fragment of the EGF-like domain mediating integrin binding (Int22). The study was performed on a transgenic mouse model of AD, the 5xFAD line. Individual IgG preparations were isolated from blood and subsequently tested for peptidase activity against fluorescently labeled peptides using thin-layer chromatography and MALDI-TOF MS. During development of AD-like pathology, IgG from transgenic mice, unlike controls (C57BL/6 line), hydrolyzed all three peptides with increased efficiency. The relative activity of hydrolysis of C22 and EGF23 continuously increased with disease progression and reached a maximum at advanced stages, whereas the activity toward Int22 changed only slightly. At the onset of pathology, antibodies hydrolyzed C22 and EGF23 at two and one sites, respectively, whereas by the stage of advanced pathology, the number of cleavage sites for both peptides increased to eight, indicating a qualitative restructuring of the catalytic potential of IgG during the progression of AD.

Related

  1. HMGB1 in Amyloid-Beta Pathology: Mechanistic Insights and Therapeutic Implications for Alzheimer’s Disease
    Song-I Seol, Ji-Eun Kim, Dashdulam Davaanyam +5
    International journal of molecular sciencesPeer-reviewedCC BYFull textGeneral biochemistryEurope PMC
  2. Pyroptosis: a potential target and research progress of exercise in ameliorating Alzheimer's disease pathology.
    Shao Jie, Zhu Lei
    Frontiers in aging neurosciencePeer-reviewedCC BYFull textMolecular biology & gene regulationEurope PMC
  3. Two functionally distinct amyloid-β intermediates link aggregation pathways to pathology in Alzheimer's disease
    A. Urbanek, A. J. Dear, D. P. Rhodes +14
    bioRxivPreprintCC BY-NC-NDFull textBiophysicsbioRxiv
  4. Development and open-source release of a multi-cancer module for structuring pathology reports
    Phillip Park, Yeonho Choi, Soobin Park +8
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textMolecular biology & gene regulationCrossref
  5. Large Language Model Framework for Structured Biomarker Extraction and Triple-Negative Breast Cancer Identification From Pathology Reports: Development and Evaluation Study.
    Nirmit Jain, Trisha Annambhotla, Akshara Siddharthan +7
    JMIR formative researchPeer-reviewedCC BYFull textMolecular biology & gene regulationEurope PMC
BibTeX
@article{tolmacheva2026iggmediated,
  title = {{IgG-Mediated Hydrolysis of Neuregulin-1-Derived Peptides in 5xFAD Mice During the Development of Alzheimer’s Disease-like Pathology}},
  author = {Anna S. Tolmacheva and Kseniya S. Aulova and Evgeny A. Ermakov and Galina S. Chicherina and Mark M. Melamud and Anna M. Timofeeva and Georgy A. Nevinsky},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  month = nov,
  doi = {10.3390/ijms272210218},
  url = {https://www.mdpi.com/1422-0067/27/22/10218},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - IgG-Mediated Hydrolysis of Neuregulin-1-Derived Peptides in 5xFAD Mice During the Development of Alzheimer’s Disease-like Pathology
AU  - Anna S. Tolmacheva
AU  - Kseniya S. Aulova
AU  - Evgeny A. Ermakov
AU  - Galina S. Chicherina
AU  - Mark M. Melamud
AU  - Anna M. Timofeeva
AU  - Georgy A. Nevinsky
PY  - 2026
DA  - 2026/11/14
JO  - International Journal of Molecular Sciences
DO  - 10.3390/ijms272210218
UR  - https://www.mdpi.com/1422-0067/27/22/10218
AB  - Synaptic dysfunction and neurodegeneration in Alzheimer’s disease (AD) are accompanied by neuroinflammation and peripheral immune activation. Activation of humoral immunity is known to be associated with the formation of catalytic antibodies capable of catalytically degrading various antigens. Given the key role of neuregulin-1 (NRG1) in synaptic function and inflammation, and the possible involvement of catalytic antibodies in AD pathogenesis, we investigated IgG-mediated hydrolysis of three NRG1 peptides corresponding to the linker region cleaved during NRG1 maturation (C22), a conserved segment of the EGF-like domain (EGF23), and a fragment of the EGF-like domain mediating integrin binding (Int22). The study was performed on a transgenic mouse model of AD, the 5xFAD line. Individual IgG preparations were isolated from blood and subsequently tested for peptidase activity against fluorescently labeled peptides using thin-layer chromatography and MALDI-TOF MS. During development of AD-like pathology, IgG from transgenic mice, unlike controls (C57BL/6 line), hydrolyzed all three peptides with increased efficiency. The relative activity of hydrolysis of C22 and EGF23 continuously increased with disease progression and reached a maximum at advanced stages, whereas the activity toward Int22 changed only slightly. At the onset of pathology, antibodies hydrolyzed C22 and EGF23 at two and one sites, respectively, whereas by the stage of advanced pathology, the number of cleavage sites for both peptides increased to eight, indicating a qualitative restructuring of the catalytic potential of IgG during the progression of AD.
SN  - 1422-0067
ER  -